FAAH/MAGL-IN-4

• UNSPSC Description:

  FAAH/MAGL-IN-4 (Compound 13) is a potent fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL) inhibitor with IC50s of 9.1 nM and 7.9 μM, respectively. FAAH/MAGL-IN-4 can be used for the research of pain and CNS disorders[1].

• Target Antigen:

  FAAH

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/faah-magl-in-4.html

• Purity:

  99.83

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  CCCCCCCCCC1=CC=C(C=C1)B(O)O

• Molecular Weight:

  248.175

• References & Citations:

  [1]Anna Minkkilä, et al. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  256383-45-6